Trellus Health plc
TRLS.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | £0 | £0 | £0 | £0 |
| - Cash | £0 | £0 | £0 | £0 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | -£0 | -£0 | -£0 | -£0 |
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | 360.9% | 28% | 900% | – |
| Gross Profit | £0 | £0 | £0 | £0 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -£0 | -£0 | -£0 | -£0 |
| % Margin | -1,012.5% | -6,159.4% | -8,042% | -60,440% |
| Net Income | -£0 | -£0 | -£0 | -£0 |
| % Margin | -1,015.9% | -6,079.7% | -7,782% | -55,440% |
| EPS Diluted | -0.019 | -0.024 | -0.024 | -0.017 |
| % Growth | 22.8% | 0% | -40.1% | – |
| Operating Cash Flow | -£0 | -£0 | -£0 | -£0 |
| Capital Expenditures | £0 | £0 | £0 | £0 |
| Free Cash Flow | -£0 | -£0 | -£0 | -£0 |